Dizman, N., Lyou, Y., Salgia, N., Bergerot, P. G., Hsu, J., Enriquez, D., . . . Pal, S. (2020). Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: Comprehensive genomic and transcriptomic analysis. J Immunother Cancer.
استشهاد بنمط شيكاغوDizman, Nazli, et al. "Correlates of Clinical Benefit From Immunotherapy and Targeted Therapy in Metastatic Renal Cell Carcinoma: Comprehensive Genomic and Transcriptomic Analysis." J Immunother Cancer 2020.
MLA استشهادDizman, Nazli, et al. "Correlates of Clinical Benefit From Immunotherapy and Targeted Therapy in Metastatic Renal Cell Carcinoma: Comprehensive Genomic and Transcriptomic Analysis." J Immunother Cancer 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.